SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma

BACKGROUND: Malignant mesothelioma is an aggressive, treatment-resistant tumor arising from mesothelium of pleura, peritoneum and pericardium. Despite current combined regimen, its prognosis remains dismal, calling for more effective targeted therapies. We investigated whether aberrant Hh activation...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Yi, He, Jianxing, Zhang, Fang, Li, Hui, Yue, Dongsheng, Wang, Changli, Jablons, David M, He, Biao, Lui, Natalie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622612/
https://ncbi.nlm.nih.gov/pubmed/23379358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars